120 related articles for article (PubMed ID: 27464991)
1. Recombinant production and characterization of human anti-influenza virus monoclonal antibodies identified from hybridomas fused with human lymphocytes.
Misaki R; Fukura N; Kajiura H; Yasugi M; Kubota-Koketsu R; Sasaki T; Momota M; Ono K; Ohashi T; Ikuta K; Fujiyama K
Biologicals; 2016 Sep; 44(5):394-402. PubMed ID: 27464991
[TBL] [Abstract][Full Text] [Related]
2. Human monoclonal antibodies broadly neutralizing against influenza B virus.
Yasugi M; Kubota-Koketsu R; Yamashita A; Kawashita N; Du A; Sasaki T; Nishimura M; Misaki R; Kuhara M; Boonsathorn N; Fujiyama K; Okuno Y; Nakaya T; Ikuta K
PLoS Pathog; 2013 Feb; 9(2):e1003150. PubMed ID: 23408886
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the fusion partner cell line SPYMEG for obtaining human monoclonal antibodies against influenza B virus.
Soni P; Yasuhara A; Takenaga T; Iwatsuki-Horimoto K; Uraki R; Ito M; Sasaki T; Ikuta K; Yamayoshi S; Kawaoka Y
J Vet Med Sci; 2018 Jun; 80(6):1020-1024. PubMed ID: 29669959
[TBL] [Abstract][Full Text] [Related]
4. [Epitope analysis of the hemagglutinin molecule of the Victoria lineage influenza B viruses].
Sorokin EV; Tsareva TR; Sominina AA; Pisareva MM; Komissarov AV; Kosheleva AA; Grudinin MP
Vopr Virusol; 2014; 59(6):27-31. PubMed ID: 25929033
[TBL] [Abstract][Full Text] [Related]
5. [Monoclonal antibodies to the influenza A virus matrix protein that react with viral strains of different subtypes].
Popov IA; Chervonskiĭ AV; Krivoshein IuS; Krivorutchenko IuL; Bakova AA; Fedorkina OA
Vopr Virusol; 1992; 37(3):141-4. PubMed ID: 1441439
[TBL] [Abstract][Full Text] [Related]
6. Human monoclonal antibodies derived from a patient infected with 2009 pandemic influenza A virus broadly cross-neutralize group 1 influenza viruses.
Pan Y; Sasaki T; Kubota-Koketsu R; Inoue Y; Yasugi M; Yamashita A; Ramadhany R; Arai Y; Du A; Boonsathorn N; Ibrahim MS; Daidoji T; Nakaya T; Ono K; Okuno Y; Ikuta K; Watanabe Y
Biochem Biophys Res Commun; 2014 Jul; 450(1):42-8. PubMed ID: 24858683
[TBL] [Abstract][Full Text] [Related]
7. Variables influencing anti-human immunodeficiency virus type 1 neutralizing human monoclonal antibody (NhMAb) production among infected Thais.
Akapirat S; Avihingsanon A; Ananworanich J; Schuetz A; Ramasoota P; Luplertlop N; Ono K; Ikuta K; Utachee P; Kameoka M; Leaungwutiwong P
Southeast Asian J Trop Med Public Health; 2013 Sep; 44(5):825-41. PubMed ID: 24437318
[TBL] [Abstract][Full Text] [Related]
8. [Preparation and characterization of monoclonal antibodies against M2 protein of avian influenza virus].
Li YQ; Yang J; Zhang L; Wei L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):475-8. PubMed ID: 18466706
[TBL] [Abstract][Full Text] [Related]
9. Human monoclonal antibodies to human cytomegalovirus derived from peripheral blood lymphocytes of healthy adults.
Kitamura K; Yamada K; Kuzushima K; Morishima T; Morishima Y; Yamamoto N; Nishiyama Y; Ohya K; Yamaguchi H
J Med Virol; 1990 Sep; 32(1):60-6. PubMed ID: 2173739
[TBL] [Abstract][Full Text] [Related]
10. Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanoma.
Martin RF; Kisor R; Schroer D; Eichler G; Filaccio ML
Hum Antibodies Hybridomas; 1990; 1(3):154-9. PubMed ID: 2103359
[TBL] [Abstract][Full Text] [Related]
11. Production of human monoclonal antibody to X31 influenza virus nucleoprotein.
Crawford DH; Callard RE; Muggeridge MI; Mitchell DM; Zanders ED; Beverley PC
J Gen Virol; 1983 Mar; 64 Pt 3():697-700. PubMed ID: 6298350
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009).
Cabral TM; Berhane Y; Schmidt L; Tracz DM; Hole K; Leith M; Corbett CR
J Virol Methods; 2012 Jul; 183(1):25-33. PubMed ID: 22575685
[TBL] [Abstract][Full Text] [Related]
13. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
14. Human X (mouse X human) hybridomas stably producing human antibodies.
Ostberg L; Pursch E
Hybridoma; 1983; 2(4):361-7. PubMed ID: 6678802
[TBL] [Abstract][Full Text] [Related]
15. Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells.
Tamminen WL; Wraith D; Barber BH
Eur J Immunol; 1987 Jul; 17(7):999-1006. PubMed ID: 3497045
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of IgG2a-reactive autoantibodies from influenza virus-infected BALB/c mice.
Fazekas G; Rajnavölgyi E; Kurucz I; Sintár E; Kiss K; László G; Gergely J
Eur J Immunol; 1990 Dec; 20(12):2719-29. PubMed ID: 2269331
[TBL] [Abstract][Full Text] [Related]
17. [Hybridomas producing monoclonal antibodies to influenza viruses].
Kushch AA; Tsoĭ LA; Isaeva EI; Rovnova ZI; Ivanova LA
Vopr Virusol; 1985; 30(1):22-4. PubMed ID: 3887755
[TBL] [Abstract][Full Text] [Related]
18. The production of equine monoclonal immunoglobulins by horse-mouse heterohybridomas.
Richards CM; Aucken HA; Tucker EM; Hannant D; Mumford JA; Powell JR
Vet Immunol Immunopathol; 1992 Jun; 33(1-2):129-43. PubMed ID: 1632074
[TBL] [Abstract][Full Text] [Related]
19. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies.
Yu X; McGraw PA; House FS; Crowe JE
J Immunol Methods; 2008 Jul; 336(2):142-51. PubMed ID: 18514220
[TBL] [Abstract][Full Text] [Related]
20. [Isolation and characteristics of monoclonal antibodies to influenza virus types A and B].
Busse TL; Khristova ML; Sokolova MV; Kharitonenkov IG; Saranpa M
Vopr Virusol; 1988; 33(5):543-7. PubMed ID: 3064429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
